Nashville, TN, United States of America

Sheila Downs


Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sheila Downs

Introduction

Sheila Downs is a prominent inventor based in Nashville, TN, known for her significant contributions to the field of biotechnology. With a total of two patents to her name, she has made remarkable strides in the delivery of biologically active molecules into cells. Her work has the potential to impact various therapeutic areas, particularly in treating inflammatory conditions.

Latest Patents

Sheila Downs' latest patents include innovative compositions for importing biologically active molecules into cells. The first patent focuses on the delivery of molecules such as peptides, nucleic acids, and therapeutic agents by utilizing a complex linked to an importation competent signal peptide. This method can be applied in peptide therapy, gene transfer, and antisense therapy to manage systemic inflammatory response syndromes like endotoxic shock. The second patent involves cell-permeable peptides aimed at inhibiting inflammatory reactions. This invention also emphasizes the delivery of biologically active molecules into cells, targeting inflammatory conditions such as autoimmune diseases and localized inflammatory reactions.

Career Highlights

Sheila Downs is affiliated with Vanderbilt University, where she continues her research and development in the field of biotechnology. Her work is characterized by a strong focus on innovative solutions for complex medical challenges.

Collaborations

Sheila has collaborated with notable colleagues, including Jack Jacek Hawiger and Daniel Robinson, who share her commitment to advancing scientific knowledge and therapeutic applications.

Conclusion

Sheila Downs exemplifies the spirit of innovation in biotechnology through her patents and research efforts. Her contributions are paving the way for new therapeutic strategies to combat inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…